Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Gatanaga

Showing results (41-50 of 274) with videos related to

Pageof 28
Sort By:
Antiviral Research|February 21, 2006
Cooperative contribution of gag substitutions to nelfinavir-dependent enhancement of precursor cleavage and replication of human immunodeficiency virus type-1Saori Matsuoka-Aizawa, Hiroyuki Gatanaga, Hironori Sato, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
Decreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cellsTatsuyoshi Kawamura, Hiroyuki Gatanaga, Debra L Borris, et al.
Biomedical Chromatography : BMC|August 2, 2017
High-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of raltegravir, dolutegravir and elvitegravir concentrations in human plasma and cerebrospinal fluid samplesKiyoto Tsuchiya, Mayu Ohuchi, Naoe Yamane, et al.
Plos One|March 18, 2016
High Mortality of Disseminated Non-Tuberculous Mycobacterial Infection in HIV-Infected Patients in the Antiretroviral Therapy EraTetsuro Kobayashi, Takeshi Nishijima, Katsuji Teruya, et al.
Plos One|June 1, 2013
Preemptive therapy prevents cytomegalovirus end-organ disease in treatment-naïve patients with advanced HIV-1 infection in the HAART eraDaisuke Mizushima, Takeshi Nishijima, Hiroyuki Gatanaga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
Dilated cardiomyopathy in an adult human immunodeficiency virus type 1-positive patient treated with a zidovudine-containing antiretroviral regimenJunko Tanuma, Azumi Ishizaki, Hiroyuki Gatanaga, et al.
AIDS (London, England)|February 18, 2010
Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistanceHiroyuki Gatanaga, Hirotaka Ode, Atsuko Hachiya, et al.
Plos One|December 17, 2013
High prevalence of illicit drug use in men who have sex with men with HIV-1 infection in JapanTakeshi Nishijima, Hiroyuki Gatanaga, Hirokazu Komatsu, et al.
AIDS Research and Human Retroviruses|August 2, 2014
Brain magnetic resonance imaging screening is not useful for HIV-1-infected patients without neurological symptomsTakeshi Nishijima, Hiroyuki Gatanaga, Katsuji Teruya, et al.
AIDS (London, England)|February 27, 2016
Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapyTakeshi Nishijima, Takuma Kurosawa, Noriko Tanaka, et al.
Pageof 28

Showing results (41-50 of 274) with videos related to

Sort By:
Pageof 28
Antiviral Research|February 21, 2006
Cooperative contribution of gag substitutions to nelfinavir-dependent enhancement of precursor cleavage and replication of human immunodeficiency virus type-1Saori Matsuoka-Aizawa, Hiroyuki Gatanaga, Hironori Sato, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
Decreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cellsTatsuyoshi Kawamura, Hiroyuki Gatanaga, Debra L Borris, et al.
Biomedical Chromatography : BMC|August 2, 2017
High-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of raltegravir, dolutegravir and elvitegravir concentrations in human plasma and cerebrospinal fluid samplesKiyoto Tsuchiya, Mayu Ohuchi, Naoe Yamane, et al.
Plos One|March 18, 2016
High Mortality of Disseminated Non-Tuberculous Mycobacterial Infection in HIV-Infected Patients in the Antiretroviral Therapy EraTetsuro Kobayashi, Takeshi Nishijima, Katsuji Teruya, et al.
Plos One|June 1, 2013
Preemptive therapy prevents cytomegalovirus end-organ disease in treatment-naïve patients with advanced HIV-1 infection in the HAART eraDaisuke Mizushima, Takeshi Nishijima, Hiroyuki Gatanaga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
Dilated cardiomyopathy in an adult human immunodeficiency virus type 1-positive patient treated with a zidovudine-containing antiretroviral regimenJunko Tanuma, Azumi Ishizaki, Hiroyuki Gatanaga, et al.
AIDS (London, England)|February 18, 2010
Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistanceHiroyuki Gatanaga, Hirotaka Ode, Atsuko Hachiya, et al.
Plos One|December 17, 2013
High prevalence of illicit drug use in men who have sex with men with HIV-1 infection in JapanTakeshi Nishijima, Hiroyuki Gatanaga, Hirokazu Komatsu, et al.
AIDS Research and Human Retroviruses|August 2, 2014
Brain magnetic resonance imaging screening is not useful for HIV-1-infected patients without neurological symptomsTakeshi Nishijima, Hiroyuki Gatanaga, Katsuji Teruya, et al.
AIDS (London, England)|February 27, 2016
Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapyTakeshi Nishijima, Takuma Kurosawa, Noriko Tanaka, et al.
Pageof 28